• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉和动脉血栓栓塞的遗传学

The genetics of venous and arterial thromboembolism.

作者信息

Lillicrap D

机构信息

Department of Pathology, Queen's University, 99 University Avenue, Kingston, Ontario, K7L 3N6, Canada.

出版信息

Curr Atheroscler Rep. 2001 May;3(3):209-15. doi: 10.1007/s11883-001-0063-2.

DOI:10.1007/s11883-001-0063-2
PMID:11286642
Abstract

There is substantial evidence to indicate that the pathologic processes of venous and arterial thromboembolism involve both genetic and environmental influences. Scientific progress over the past decade has revealed a growing number of genetic factors, such as factor V Leiden and the prothrombin gene variant, that are present in more than 1% of the population and increase the relative risk of venous thrombosis between two- and sevenfold. Furthermore, several of these factors have been demonstrated to interact adversely with environmental influences, such as oral contraceptives and smoking. Although these traits are present at relatively high prevalence in the population, the magnitude of the increased thrombotic risk associated with these factors is substantially less than that related to inherited deficiency of the natural anticoagulant protein antithrombin, and somewhat less than the elevated risk with protein C and protein S deficiencies. In contrast to the progress that has been made in understanding the genetic contributions to venous thromboembolism, much still remains to be learned about the genetic basis of arterial thrombosis. Despite the documentation of associations between several genetic polymorphisms with plasma procoagulant levels, consistent associations with arterial thrombotic disease have not been found.

摘要

有大量证据表明,静脉和动脉血栓栓塞的病理过程涉及遗传和环境因素。过去十年的科学进展揭示了越来越多的遗传因素,如凝血因子V莱顿突变和凝血酶原基因变异,这些因素在超过1%的人群中存在,并使静脉血栓形成的相对风险增加两到七倍。此外,已证实其中一些因素会与环境因素产生不良相互作用,如口服避孕药和吸烟。尽管这些特征在人群中的患病率相对较高,但与这些因素相关的血栓形成风险增加幅度远低于与天然抗凝蛋白抗凝血酶遗传性缺乏相关的风险,也略低于蛋白C和蛋白S缺乏时的风险升高幅度。与在理解静脉血栓栓塞的遗传因素方面取得的进展相比,关于动脉血栓形成的遗传基础仍有许多有待了解之处。尽管有文献记录了几种基因多态性与血浆促凝水平之间的关联,但尚未发现与动脉血栓性疾病的一致关联。

相似文献

1
The genetics of venous and arterial thromboembolism.静脉和动脉血栓栓塞的遗传学
Curr Atheroscler Rep. 2001 May;3(3):209-15. doi: 10.1007/s11883-001-0063-2.
2
Genetic polymorphisms associated with venous and arterial thrombosis: an overview.与静脉和动脉血栓形成相关的基因多态性:综述
Arch Pathol Lab Med. 2002 Mar;126(3):295-304. doi: 10.5858/2002-126-0295-GPAWVA.
3
Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis.凝血因子基因多态性及其对动脉和静脉血栓形成的影响。
Clin Chim Acta. 2003 Apr;330(1-2):31-55. doi: 10.1016/s0009-8981(03)00022-6.
4
[A new mutation in the prothrombin gene (G20210A) and the risk for venous and arterial thromboembolism].凝血酶原基因新突变(G20210A)与静脉和动脉血栓栓塞风险
Harefuah. 2000 Jul;139(1-2):51-6.
5
Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.伴有遗传性易栓缺陷的凝血因子V莱顿突变携带者发生静脉血栓栓塞的风险:一项回顾性分析。
Blood Coagul Fibrinolysis. 2001 Dec;12(8):713-20. doi: 10.1097/00001721-200112000-00014.
6
Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.凝血因子V莱顿突变与血栓栓塞性疾病风险:临床视角
Ann Intern Med. 1997 Nov 15;127(10):895-903. doi: 10.7326/0003-4819-127-10-199711150-00007.
7
Genetic variations observed in arterial and venous thromboembolism--relevance for therapy, risk prevention and prognosis.动脉和静脉血栓栓塞中观察到的基因变异——对治疗、风险预防和预后的相关性。
Clin Chem Lab Med. 2003 Apr;41(4):496-500. doi: 10.1515/CCLM.2003.075.
8
Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene.凝血酶原基因G20210A多态性的年轻或老年杂合携带者首次静脉血栓栓塞的不同情况。
Haematologica. 2003 Jan;88(1):61-6.
9
The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.因子V基因、凝血酶原基因或二者均发生突变的家庭成员发生静脉血栓栓塞的风险。
Br J Haematol. 2000 Dec;111(4):1223-9. doi: 10.1046/j.1365-2141.2000.02502.x.
10
[Incidence and risk factors for venous thromboembolism].[静脉血栓栓塞症的发病率及危险因素]
Rev Prat. 2007 Apr 15;57(7):711-3, 716, 719-20.

本文引用的文献

1
The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.因子V基因、凝血酶原基因或二者均发生突变的家庭成员发生静脉血栓栓塞的风险。
Br J Haematol. 2000 Dec;111(4):1223-9. doi: 10.1046/j.1365-2141.2000.02502.x.
2
Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden--cost-effectiveness analysis.
Thromb Haemost. 2000 Nov;84(5):752-7.
3
How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation.如何确定携带凝血因子V莱顿突变者的抗凝治疗最佳疗程。
Thromb Haemost. 2000 Nov;84(5):740-1.
4
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism.脂蛋白(a)水平升高作为静脉血栓栓塞的独立危险因素。
Blood. 2000 Nov 15;96(10):3364-8.
5
Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia.
Br J Haematol. 2000 Jun;109(3):519-22. doi: 10.1046/j.1365-2141.2000.02091.x.
6
Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group.血管性血友病因子水平升高与I型糖尿病患者中血管性血友病因子(vWF)基因Thr789Ala多态性相关,但与肾病无关。GENEDIAB研究组和DESIR研究组。
Kidney Int. 2000 Apr;57(4):1437-43. doi: 10.1046/j.1523-1755.2000.00988.x.
7
Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S.蛋白S遗传性缺陷家族中的基因分析、表型诊断及静脉血栓形成风险
Blood. 2000 Mar 15;95(6):1935-41.
8
A Thai patient with the mutation of Arg306 of FV gene identical to the Hong Kong but not to the Cambridge type.一名泰国患者的FV基因第306位精氨酸发生突变,该突变与香港型相同,但与剑桥型不同。
Thromb Haemost. 1999 Nov;82(5):1553-4.
9
Thrombophilia-associated pregnancy wastage.血栓形成倾向相关的妊娠丢失
Fertil Steril. 1999 Nov;72(5):765-74. doi: 10.1016/s0015-0282(99)00360-x.
10
Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden).
Blood. 1999 Nov 1;94(9):3062-6.